Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Enveric Biosciences, Inc. Director's Dealing 2021

Jan 8, 2021

35460_dirs_2021-01-08_39697535-e11c-46d1-a4eb-4f2b13b86572.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Enveric Biosciences, Inc. (ENVB)
CIK: 0000890821
Period of Report: 2020-12-30

Reporting Person: Johnson David Ian (Director, CEO and Chairman)

More from Enveric Biosciences, Inc.

Regulatory Filings 2026
May 29
Interim / Quarterly Report 2026
May 15
Regulatory Filings 2026
May 15
Regulatory Filings 2026
May 4
Regulatory Filings 2026
Apr 30
Proxy Solicitation & Information Statement 2026
Apr 30
Regulatory Filings 2026
Apr 30
Regulatory Filings 2026
Apr 29
Regulatory Filings 2026
Apr 23
Regulatory Filings 2026
Apr 18
View all filings →